Current management and screening of peripheral and coronary artery disease in people with diabetes mellitus in Europe. The PADDIA/CADDIA survey. - 2022
Atherosclerosis; Coronary artery disease; Diabetes; Peripheral artery disease; Treatment; Europe/epidemiology; Humans; Risk Factors; Surveys and Questionnaires; Cardiovascular Diseases/prevention & control; Coronary Artery Disease/diagnosis; Coronary Artery Disease/epidemiology; Diabetes Mellitus, Type 2/complications; Diabetes Mellitus, Type 2/diagnosis; Diabetes Mellitus, Type 2/epidemiology; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Europe; Internal Medicine; Endocrinology, Diabetes and Metabolism; Endocrinology
Abstract :
[en] [en] AIMS: This survey aimed to evaluate the current management and screening of coronary artery disease and peripheral artery disease in people with type 2 diabetes mellitus (T2DM) in Europe, utilizing the 2013 ESC/EASD (European Society of Cardiology/European Association for the Study of Diabetes) guidelines as a benchmark.
METHODS: The PADDIA/CADDIA survey is a European medical research collaboration targeting cardiologists, vascular physicians, diabetologists and general practitioners from Austria, Belgium, France, Germany, Italy, Netherlands and United Kingdom.
RESULTS: The questionnaire was completed by sixty-three physicians, of whom 75% declared assessing the cardiovascular risk of people with T2DM mostly without using a risk score (59%). More than 90% of the panel, check HbA1c, blood pressure and low-density lipoprotein cholesterol targets in their patients with T2DM and coronary or peripheral artery disease. For 94% the presence of T2DM influence their patients' management, by optimizing blood glucose, blood pressure and low-density lipoprotein cholesterol control. Only 37% considered screening for lower extremity peripheral artery disease among their T2DM patients and 35% among those with cardiovascular disease.
CONCLUSIONS: Physicians mostly follow the ESC/EASD 2013 guidelines, but when it comes to screening for additional conditions including coronary artery disease or peripheral artery disease, or intensifying the antithrombotic regimen there is need for better guidance.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Mahe, Guillaume; Vascular Medicine and Investigation Department, INSERM CIC-1414, University of Rennes 2, M2S - EA 7470, F-35000 Rennes, France, Pôle imagerie médicale et explorations fonctionnelles, Hôpital Pontchaillou, 2 rue Henri Le Guilloux, Rennes F-35033, France. Electronic address: maheguillaume@yahoo.fr
Brodmann, Marianne; Division of Angiology, Department of Internal Medicine, Medical University Graz, Auenbruggerplatz 27, 8036 Graz, Austria
Capodanno, Davide; Division of Cardiology, Azienda Ospedaliero Universitaria Policlinico "G. Rodolico-San Marco", University of Catania, Catania, Italy
Ceriello, Antonio; IRCCS MultiMedica, Via Milanese, 300, 20099 Sesto San Giovanni, Milan, Italy
Cuisset, Thomas; Département of Cardiology, Chu Timone, 264 Rue Saint-Pierre, 13005 Marseille, France
Delgado, Victoria; Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, the Netherlands
Espinola-Klein, Christine; Department of Cardiology, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany
Johnson, Thomas W; Bristol Heart Institute, University Hospitals Bristol & Weston NHS Foundation Trust, Bristol BS2 8HW, United Kingdom
Sprynger, Muriel ; Université de Liège - ULiège > Département des sciences cliniques
Sattar, Naveed; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom
Williams, R., Karuranga, S., Malanda, B., Saeedi, P., Basit, A., Besançon, S., et al. Global and regional estimates and projections of diabetes-related health expenditure: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Practice., 162, 2020.
Preis, S.R., Hwang, S.-J., Coady, S., Pencina, M.J., D'Agostino, R.B., Savage, P.J., et al. Trends in All-Cause and Cardiovascular Disease Mortality among Women and Men with and without Diabetes in the Framingham Heart Study, 1950–2005. Circulation 119:13 (2009), 1728–1735.
Leon, B.M., Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. WJD, 6(13), 2015, 1246, 10.4239/wjd.v6.i13.1246.
Cosentino, F., Grant, P.J., Aboyans, V., Bailey, C.J., Ceriello, A., Delgado, V., et al. ESC Scientific Document Group. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 41:2 (2020), 255–323.
The Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 375:9733 (2010), 2215–2222.
Hoke, M., Schillinger, M., Minar, E., Goliasch, G., Binder, C.J., Mayer, F.J., Carotid ultrasound investigation as a prognostic tool for patients with diabetes mellitus. Cardiovasc Diabetol, 18, 2019, 90.
Association, A.D., Peripheral Arterial Disease in People With Diabetes. Diabetes Care 26:12 (2003), 3333–3341.
Bax, J.J., Young, L.H., Frye, R.L., Bonow, R.O., Steinberg, H.O., Barrett, E.J., Screening for Coronary Artery Disease in Patients With Diabetes. Diabetes Care 30:10 (2007), 2729–2736.
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Revista Española de Cardiología (English Edition). 67(2):2014;136.
Association AD. 7. Diabetes Technology: Standards of Medical Care in Diabetes—2020. Diabetes Care. 43(Supplement 1):2020;S77–88.
Piepoli, M.F., Hoes, A.W., Agewall, S., Albus, C., Brotons, C., Catapano, A.L., et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 37:29 (2016), 2315–2381.
Mogensen, C.E., Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset Diabetes. N Engl J Med 310:6 (1984), 356–360.
Pontremoli, R., Microalbuminuria Is an Early Marker of Target Organ Damage in Essential Hypertension. Ame J Hypertens 11:4 (1998), 430–438.
Gami, A.S., Garovic, V.D., Contrast Nephropathy After Coronary Angiography. Mayo Clinic Proc 79:2 (2004), 211–219.
Young, L.H., Wackers, F.J.T., Chyun, D.A., Davey, J.A., Barrett, E.J., Taillefer, R., et al. Cardiac Outcomes After Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes: The DIAD Study: A Randomized Controlled Trial. JAMA, 301(15), 2009, 1547, 10.1001/jama.2009.476.
Cosson, E., Nguyen, M.T., Chanu, B., Banu, I., Chiheb, S., Balta, C., et al. Cardiovascular risk prediction is improved by adding asymptomatic coronary status to routine risk assessment in type 2 diabetic patients. Diabetes Care 34:9 (2011), 2101–2107.
Valensi, P., Henry, P., Boccara, F., Cosson, E., Prevost, G., Emmerich, J., et al. Risk stratification and screening for coronary artery disease in asymptomatic patients with diabetes mellitus: Position paper of the French Society of Cardiology and the French-speaking Society of Diabetology. Diabetes Metabol, 47(2), 2021.
Gerhard-Herman, M.D., Gornik, H.L., Barrett, C., Barshes, N.R., Corriere, M.A., Drachman, D.E., et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary. Circulation 135:12 (2017), e686–e725.
Aboyans, V., Ricco, J.-B., Bartelink, M.-L.E.L., Björck, M., Brodmann, M., Cohnert, T., et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J 39:9 (2018), 763–816.
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). The Lancet. 348(9038):1996;1329–39.
Eikelboom, J.W., Connolly, S.J., Bosch, J., Dagenais, G.R., Hart, R.G., Shestakovska, O., et al. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. N Engl J Med 377:14 (2017), 1319–1330.
Bhatt, D.L., Eikelboom, J.W., Connolly, S.J., Steg, P.G., Anand, S.S., Verma, S., et al. Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease: Insights From the COMPASS Trial. Circulation 141:23 (2020), 1841–1854.
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 37:3 (2016), 267–315.
Khunti, K., Ceriello, A., Cos, X., De Block, C., Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: A meta-analysis. Diabetes Res Clin Practice 137 (2018), 137–148.
Okoli, C., Pawlowski, S.D., The Delphi method as a research tool: an example, design considerations and applications. Informat Manage 42:1 (2004), 15–29.
